KR102573041B1 - Composition for skin moisturizing comprising Capsosiphon fulvescens extract as effective component - Google Patents
Composition for skin moisturizing comprising Capsosiphon fulvescens extract as effective component Download PDFInfo
- Publication number
- KR102573041B1 KR102573041B1 KR1020200021394A KR20200021394A KR102573041B1 KR 102573041 B1 KR102573041 B1 KR 102573041B1 KR 1020200021394 A KR1020200021394 A KR 1020200021394A KR 20200021394 A KR20200021394 A KR 20200021394A KR 102573041 B1 KR102573041 B1 KR 102573041B1
- Authority
- KR
- South Korea
- Prior art keywords
- skin
- extract
- maesaengi
- moisturizing
- present
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 230000003020 moisturizing effect Effects 0.000 title claims abstract description 30
- 241001200842 Capsosiphon fulvescens Species 0.000 title claims description 6
- 239000000284 extract Substances 0.000 title abstract description 38
- 239000002537 cosmetic Substances 0.000 claims abstract description 22
- 239000004480 active ingredient Substances 0.000 claims abstract description 12
- 230000036541 health Effects 0.000 claims abstract description 11
- 235000013305 food Nutrition 0.000 claims abstract description 10
- 235000013376 functional food Nutrition 0.000 claims description 12
- 239000000469 ethanolic extract Substances 0.000 claims description 9
- 230000003796 beauty Effects 0.000 claims description 6
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 claims description 3
- 230000002708 enhancing effect Effects 0.000 claims 2
- 210000003491 skin Anatomy 0.000 abstract description 51
- 230000008591 skin barrier function Effects 0.000 abstract description 17
- 210000000434 stratum corneum Anatomy 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 11
- 230000006870 function Effects 0.000 abstract description 11
- 238000005728 strengthening Methods 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 26
- 210000004027 cell Anatomy 0.000 description 17
- 102100028314 Filaggrin Human genes 0.000 description 12
- 101710088660 Filaggrin Proteins 0.000 description 12
- 102000007236 involucrin Human genes 0.000 description 12
- 108010033564 involucrin Proteins 0.000 description 12
- 210000002510 keratinocyte Anatomy 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 238000009472 formulation Methods 0.000 description 9
- -1 body cleanser Substances 0.000 description 8
- 230000003833 cell viability Effects 0.000 description 8
- 239000006071 cream Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000006210 lotion Substances 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 210000002615 epidermis Anatomy 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 231100000002 MTT assay Toxicity 0.000 description 3
- 238000000134 MTT assay Methods 0.000 description 3
- 239000004909 Moisturizer Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 210000004927 skin cell Anatomy 0.000 description 3
- 230000037380 skin damage Effects 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- 240000007087 Apium graveolens Species 0.000 description 2
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 2
- 235000010591 Appio Nutrition 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000000809 air pollutant Substances 0.000 description 2
- 231100001243 air pollutant Toxicity 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 230000003780 keratinization Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000012679 serum free medium Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108700041153 Filaggrin Proteins Proteins 0.000 description 1
- 240000000950 Hippophae rhamnoides Species 0.000 description 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 239000012083 RIPA buffer Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 206010048218 Xeroderma Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- HOWJQLVNDUGZBI-UHFFFAOYSA-N butane;propane Chemical compound CCC.CCCC HOWJQLVNDUGZBI-UHFFFAOYSA-N 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 230000001120 cytoprotective effect Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000003752 hydrotrope Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 206010021198 ichthyosis Diseases 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036555 skin type Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9722—Chlorophycota or Chlorophyta [green algae], e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/202—Algae extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 매생이 추출물을 유효성분으로 포함하는 피부 보습용 조성물에 관한 것으로, 본 발명의 매생이 추출물은 피부 보습 및 피부 장벽 강화 효과가 우수하므로 외부 자극에 의해 손상된 피부 각질층의 회복을 위한 화장품 및 건강기능식품의 개발 소재로써 유용하게 활용될 수 있을 것이다.The present invention relates to a composition for moisturizing skin containing an extract of Maesaengi as an active ingredient. Since the extract of Maesaengi of the present invention has excellent skin moisturizing and skin barrier strengthening effects, cosmetics and health functions for restoring the stratum corneum of the skin damaged by external stimuli. It can be usefully used as a food development material.
Description
본 발명은 매생이 추출물을 유효성분으로 포함하는 피부 보습용 조성물에 관한 것이다.The present invention relates to a skin moisturizing composition comprising an extract of Maesaengi as an active ingredient.
피부의 최외각에 위치한 표피(epidermis)의 가장 중요한 기능은 다양한 외부 자극(화학물질, 대기오염물질, 건조한 환경, 자외선 등의 물리 및 화학적 자극인자)에 대한 방어와 피부를 통한 체내 수분의 과도한 발산을 막는 보호 기능이며, 이러한 보호 기능은 각질형성세포로 구성된 각질층이 정상적으로 형성되어 있을 때 그 기능을 유지할 수 있다. 표피의 가장 바깥쪽에 존재하는 각질층(stratum corneum, horney layer)은 각질형성세포로부터 형성되고 분화가 완결된 각질세포와 그를 둘러싼 지질층으로 구성되어 있다. 각질세포는 표피 최하층의 기저세포(basal cell)가 지속적으로 증식(proliferation)하면서 단계적으로 형태 및 기능상의 변화를 거쳐 피부 표면까지 상승한 세포이며, 일정 기간이 경과하면 오래된 각질세포는 피부에서 탈락되고 새로운 각질세포가 그 기능을 대신하게 되는데, 이러한 반복적인 일련의 변화 과정을 '표피세포의 분화' 또는 '각화(keratinization)'라고 부른다. 또한, 각화과정에서 각질형성세포는 천연 보습 인자(Natural moisturizing factor, NMF)와 세포간 지방질(세라마이드, 콜레스테롤, 지방산) 생성을 통해 각질층을 형성하여 각질층의 견고함과 유연성을 유지시켜 피부 장벽(skin barrier)으로서의 기능을 보유하게 한다.The most important function of the epidermis, located in the outermost layer of the skin, is to defend against various external stimuli (physical and chemical stimulants such as chemicals, air pollutants, dry environment, and ultraviolet rays) and to release excessive moisture in the body through the skin. This protective function can maintain its function when the stratum corneum composed of keratinocytes is normally formed. The outermost stratum corneum (horney layer) of the epidermis is formed from keratinocytes and is composed of keratinocytes with complete differentiation and a lipid layer surrounding them. Keratinocytes are cells that ascend to the surface of the skin through morphological and functional changes step by step as basal cells in the lowermost layer of the epidermis continuously proliferate. After a certain period of time, old keratinocytes are eliminated from the skin and new Keratinocytes take over their functions, and this repetitive series of changes is called 'differentiation of epidermal cells' or 'keratinization'. In addition, during the keratinization process, keratinocytes form the stratum corneum through the production of natural moisturizing factor (NMF) and intercellular lipids (ceramide, cholesterol, fatty acid) to maintain the firmness and flexibility of the stratum corneum, thereby maintaining the skin barrier (skin barrier). function as a barrier).
이러한 각질층은 과도한 세안이나 목욕 등의 생활 습관적 요소, 건조한 대기오염 물질 등의 환경적인 요인 및 아토피성 피부나 노인성 피부 같은 내인성 질환 등으로 인해 쉽게 그 기능이 손실될 수 있다. 따라서, 적절한 피부 수분을 유지하기 위하여 외부로부터 수분을 공급하거나 체내로부터의 수분 손실을 방지하기 위한 연구가 다양하게 진행되어 왔으며, 실제로 수분 보유 능력이 있는 다양한 보습제(moisturizer)가 개발되고 있다. 피부 보습제로는 세라마이드 등의 지질성분과 필수지방산 및 지질복합체 등 각질층에서의 수분 보유를 증가시킬 수 있는 물질을 사용하는 것이 일반적이다. This stratum corneum can easily lose its function due to lifestyle factors such as excessive washing or bathing, environmental factors such as dry air pollutants, and endogenous diseases such as atopic skin or senile skin. Therefore, in order to maintain proper skin moisture, various studies have been conducted to supply moisture from the outside or to prevent moisture loss from the body, and various moisturizers having the ability to actually retain moisture have been developed. As a skin moisturizer, it is common to use substances capable of increasing water retention in the stratum corneum, such as lipid components such as ceramide, essential fatty acids, and lipid complexes.
최근 피부에 대한 위해 요인이 점점 증가하고 있고 식생활 양상의 변화로 인해 각질형성세포의 기능이 저하되어 각질층의 보습 인자와 지질의 양이 감소하여 각질층이 정상적인 피부 장벽 기능을 발휘하지 못하는 피부를 가진 사람들이 증가하는 추세이다. 이런 피부 장벽 기능의 와해는 피부건조증, 아토피 피부염, 접촉성 피부염, 건선 등의 다양한 피부 질환을 유발한다. 이와 같은 질환들은 기존의 통상적인 수분 보유 기능을 갖는 보습제를 통해 증상완화를 기대할 수 있지만 근본적인 치유가 어렵고, 최근에는 단순한 수분보충 보다는 피부에서 가장 중요한 피부 장벽 기능의 회복에 관심이 집중되고 있다.Recently, the risk factors for the skin are gradually increasing, and the function of keratinocytes is reduced due to changes in dietary habits, and the amount of moisturizing factors and lipids in the stratum corneum is reduced. This is a growing trend. Disruption of this skin barrier function causes various skin diseases such as xeroderma, atopic dermatitis, contact dermatitis, and psoriasis. Although these diseases can be expected to relieve symptoms through conventional moisturizers having a water retention function, fundamental healing is difficult, and recently, attention has been focused on restoring the most important skin barrier function in the skin rather than simple moisture supplementation.
매생이(Capsosiphon fulvescens)는 갈매패목의 녹조류 식물로, 몸은 관상 또는 편압상이며 짙은 녹색을 띠고 있다. 길이 15cm, 굵기 2~5mm까지 달하는 단조체로서 외견상 창자파래(Enteromorpha intestinalis)의 어린 것과 같고, 질이 매우 연약하고 미끌미끌하다. 또한, 매생이에는 철분, 칼륨, 단백질 등이 많이 함유되어 있고 특유의 향과 맛을 지니고 있어 식용으로 널리 이용되고 있다.Maesaengi ( Capsosiphon fulvescens ) is a green algae plant of the order of sea buckthorn, and its body is tubular or flat and dark green. It is a single body with a length of 15 cm and a thickness of 2 to 5 mm . In addition, maesaengi contains a lot of iron, potassium, protein, etc., and has a unique aroma and taste, so it is widely used for food.
한편, 한국등록특허 제0542446호에는 미백, 항산화, 콜라겐 합성 및 피부세포 사멸 억제 효과를 가진 "매생이 추출물을 주요 활성성분으로 하는 화장료 조성물"이 개시되어 있으나, 본 발명의 매생이 추출물을 유효성분으로 포함하는 피부 보습용 조성물에 대해서는 기재된 바가 없다.On the other hand, Korean Patent Registration No. 0542446 discloses a "cosmetic composition containing Maesaengi extract as a main active ingredient" having whitening, antioxidant, collagen synthesis, and skin cell death inhibitory effects, but containing the Maesaengi extract of the present invention as an active ingredient. There is no description about the composition for moisturizing the skin.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명자들은 매생이를 대상으로 에탄올을 이용하여 추출물을 제조하여 피부각질세포에 처리한 결과, 자외선(ultraviolet) 조사에 의해 감소된 세포의 생존율과 피부 보습 및 피부 장벽 기능과 관련된 필라그린(filaggrin) 및 인볼루크린(involucrin) 단백질의 발현 수준이 증가되는 것을 확인함으로써, 본 발명을 완성하였다.The present invention has been derived from the above needs, and the present inventors prepared an extract using ethanol for falconer, and as a result of treating keratinocytes, the survival rate of cells reduced by ultraviolet irradiation and the skin The present invention was completed by confirming that the expression levels of filaggrin and involucrin proteins related to moisturizing and skin barrier functions were increased.
상기 과제를 해결하기 위해, 본 발명은 매생이(Capsosiphon fulvescens) 추출물을 유효성분으로 포함하는 피부 보습용 화장료 조성물을 제공한다.In order to solve the above problems, the present invention provides a cosmetic composition for moisturizing the skin containing an extract of Capsosiphon fulvescens as an active ingredient.
또한, 본 발명은 매생이 추출물을 유효성분으로 포함하는 자외선(ultraviolet)에 의한 피부 손상의 예방 또는 치료용 피부 외용제를 제공한다.In addition, the present invention provides a topical skin preparation for preventing or treating skin damage caused by ultraviolet rays, which includes an extract of Maesaengi as an active ingredient.
또한, 본 발명은 매생이 추출물을 유효성분으로 포함하는 피부 보습용 건강기능식품 조성물을 제공한다.In addition, the present invention provides a health functional food composition for moisturizing the skin containing an extract of Maesaengi as an active ingredient.
본 발명의 매생이 추출물은 천연에서 유래한 물질로 세포 독성이 없어 부작용이 발생할 가능성이 낮고 자외선에 대한 세포보호 효과 및 자외선 조사에 의해 감소된 피부 보습 및 피부 장벽 기능과 관련된 단백질의 발현을 증가시키는 효과가 우수하므로, 피부 보습 및 피부 장벽 강화를 위한 화장품 및 건강기능성 식품의 소재로 유용하게 활용될 수 있다.Maesaengi extract of the present invention is a naturally-derived substance, has no cytotoxicity, has low possibility of side effects, and increases the expression of proteins related to cell protection effect against ultraviolet rays and skin moisturizing and skin barrier function reduced by ultraviolet irradiation. is excellent, so it can be usefully used as a material for cosmetics and health functional foods for skin moisturizing and skin barrier reinforcement.
도 1은 피부각질세포(HaCaT)에 매생이 에탄올 추출물을 농도별(25, 50 또는 100㎍/㎖)로 처리하고 세포 생존율을 측정한 결과로, A는 HaCaT 세포에 매생이 에탄올 추출물만 처리하여 세포 생존율을 측정한 그래프이고, B는 HaCaT 세포에 매생이 에탄올 추출물을 전처리하고 자외선(UVB)을 조사한 후 세포 생존율을 측정한 그래프이다.
도 2는 HaCaT 세포에 매생이 에탄올 추출물을 전처리하고 자외선(UVB)을 조사한 후 필라그린(filaggrin; A) 및 인볼루크린(involucrin; B) 단백질의 발현 수준을 확인한 웨스턴 블롯 결과이다.Figure 1 is a result of treating skin keratinocytes (HaCaT) with an ethanol extract of Maesaengi by concentration (25, 50, or 100 μg / ml) and measuring cell viability. is a graph measuring, and B is a graph measuring cell viability after pre-treatment of HaCaT cells with an ethanol extract of Maesaengi and irradiation with ultraviolet (UVB).
Figure 2 is a Western blot result confirming the expression levels of filaggrin (A) and involucrin (B) proteins after pretreatment of HaCaT cells with an ethanol extract of Maesaengi and irradiation with ultraviolet (UVB).
본 발명의 목적을 달성하기 위하여, 본 발명은 매생이(Capsosiphon fulvescens) 추출물을 유효성분으로 포함하는 피부 보습용 화장료 조성물을 제공한다.In order to achieve the object of the present invention, the present invention provides a cosmetic composition for moisturizing the skin containing an extract of Capsosiphon fulvescens as an active ingredient.
본 발명의 피부 보습용 화장료 조성물에서, 상기 매생이 추출물은 물, 탄소수 1 내지 4의 저급 알코올 또는 이들의 혼합 용매를 이용하여 추출한 것일 수 있고, 바람직하게는 탄소수 1 내지 4의 저급 알코올일 수 있으며, 더욱 바람직하게는 에탄올을 이용하여 추출한 것일 수 있으나, 이에 제한되지 않는다.In the cosmetic composition for moisturizing skin of the present invention, the maesaengi extract may be extracted using water, a lower alcohol having 1 to 4 carbon atoms, or a mixed solvent thereof, preferably a lower alcohol having 1 to 4 carbon atoms, More preferably, it may be extracted using ethanol, but is not limited thereto.
본 발명의 일 구현 예에 따른 피부 보습용 화장료 조성물에 있어서, 상기 매생이 추출물은 물기가 제거된 생매생이 100~150g에 40~60%(v/v) 에탄올 800~1,000㎖을 첨가하고 38~42℃에서 5~7시간 동안 추출하여 제조된 것일 수 있고, 바람직하게는 물기가 제거된 생매생이 150g에 50%(v/v) 에탄올 900㎖을 첨가하고 40℃에서 6시간 동안 추출하여 제조된 것일 수 있으나, 이에 제한되지 않는다.In the cosmetic composition for moisturizing the skin according to one embodiment of the present invention, the extract of Maesaengi is added with 800 to 1,000㎖ of 40 to 60% (v/v) ethanol to 100 to 150g of dried Maesaengi and 38 to 42 It may be prepared by extracting at ° C for 5 to 7 hours, preferably prepared by adding 900 ml of 50% (v / v) ethanol to 150 g of drained raw material and extracting at 40 ° C for 6 hours. It may, but is not limited thereto.
상기 매생이 추출물은 추출 처리에 의해 얻어지는 추출액, 추출액의 희석액 또는 농축액, 추출액을 건조하여 얻어지는 건조물, 또는 조정제물 또는 정제물일 수 있으나, 이에 제한되지 않는다.The maesaengi extract may be an extract obtained by extraction treatment, a diluted or concentrated solution of the extract, a dried product obtained by drying the extract, or a crude product or purified product, but is not limited thereto.
본 발명의 피부 보습용 화장료 조성물에 있어서, 상기 매생이 추출물은 자외선(UVB) 조사에 의해 감소된 세포의 생존율과 필라그린(filaggrin) 및 인볼루크린(involucrin)의 발현량을 증가시킬 수 있으므로, 자외선 조사에 의해 손상된 피부의 보습 증진 효과 및 피부 장벽 강화 효과가 우수하다. In the cosmetic composition for moisturizing skin of the present invention, the maesaengi extract can increase the survival rate of cells reduced by ultraviolet (UVB) irradiation and the expression of filaggrin and involucrin, It is excellent in moisturizing enhancement effect and skin barrier strengthening effect of damaged skin by irradiation.
상기 용어 "피부 장벽"이란 피부 가장 바깥층인 표피의 상부층으로, 각질형성세포로 이루어진 각질층을 의미한다. 독성물질이나 미생물, 기계적 자극, 자외선에 대해 가장 중요한 일차방어선이며, 피부를 통한 전해질이나 수분손실을 억제하여 피부가 정상적인 기능을 수행할 수 있는 환경을 제공하는 기능을 한다. 또한, "피부 장벽 강화"란 피부의 가장 외각에 위치하는 각질층의 장벽 기능을 강화하는 것으로, 인볼루크린(involucrin) 또는 필라그린(filaggrin)의 발현을 증가시킴으로써 피부 보습 효과를 증가시켜 피부 장벽의 기능을 강화하는 것을 의미한다.The term "skin barrier" refers to the upper layer of the epidermis, which is the outermost layer of the skin, and refers to the stratum corneum composed of keratinocytes. It is the most important first line of defense against toxic substances, microorganisms, mechanical stimulation, and ultraviolet rays, and functions to provide an environment in which the skin can perform normal functions by suppressing electrolyte or water loss through the skin. In addition, "strengthening the skin barrier" refers to strengthening the barrier function of the stratum corneum, which is located at the outermost layer of the skin, by increasing the expression of involucrin or filaggrin, thereby increasing the skin moisturizing effect, thereby improving the skin barrier. It means to strengthen the function.
본 발명의 화장료 조성물은 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클렌징, 오일, 분말 파운데이션, 파운데이션, 왁스 파운데이션 및 스프레이 중에서 선택된 어느 하나의 제형인 것이 바람직하며, 더 바람직하게는 스킨, 스킨 소프트너, 스킨 토너, 로션, 밀크로션, 모이스쳐로션, 영양로션, 마사지크림, 영양크림, 아이크림, 모이스쳐크림, 핸드크림, 에센스, 영양에센스, 팩, 클렌징폼, 클렌징워터, 클렌징크림, 바디로션, 바디클렌져, 비누 및 파우더 중에서 선택된 어느 하나의 제형을 가질 수 있으나, 이에 제한되지 않는다. 이들 각 제형으로 이루어진 화장료 조성물은 그 제형의 제제화에 필요하고 적절한 각종의 담체와 첨가물을 함유할 수 있으며, 이들 성분의 종류와 양은 당업자에 의해 용이하게 선정될 수 있다. The cosmetic composition of the present invention is any one formulation selected from solutions, suspensions, emulsions, pastes, gels, creams, lotions, powders, soaps, surfactant-containing cleansing, oils, powder foundations, foundations, wax foundations and sprays. Preferably, skin, skin softener, skin toner, lotion, milk lotion, moisture lotion, nutrient lotion, massage cream, nutrient cream, eye cream, moisture cream, hand cream, essence, nutrient essence, pack, cleansing It may have any one formulation selected from foam, cleansing water, cleansing cream, body lotion, body cleanser, soap and powder, but is not limited thereto. The cosmetic composition composed of each of these dosage forms may contain various carriers and additives necessary and appropriate for formulation of the dosage form, and the types and amounts of these components can be easily selected by those skilled in the art.
본 발명의 화장료 조성물의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물섬유, 식물섬유, 왁스, 파라핀, 전분, 트라가칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a paste, cream or gel, animal fiber, vegetable fiber, wax, paraffin, starch, tragacanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide as a carrier component etc. can be used.
본 발명의 화장료 조성물의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판-부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the cosmetic composition of the present invention is a powder or spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component, and in particular, in the case of a spray, additional chlorofluorohydro propellants such as carbon, propane-butane or dimethyl ether.
본 발명의 화장료 조성물의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용매화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the cosmetic composition of the present invention is a solution or emulsion, a solvent, solvating agent or emulsifying agent is used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene fatty acid esters of glycol, 1,3-butylglycol oil, glycerol aliphatic esters, polyethylene glycol or sorbitan.
본 발명의 화장료 조성물의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a suspension, a liquid diluent such as water, ethanol or propylene glycol, an ethoxylated isostearyl alcohol, a suspending agent such as polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Microcrystalline cellulose, aluminum metahydroxide, bentonite, agar or tracanth and the like may be used.
본 발명의 화장료 조성물의 제형이 계면-활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르설페이트, 설포숙신산 모노에스테르, 아세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 리놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is surfactant-containing cleansing, as carrier components, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, acethionate, imidazolinium derivative, methyl taurate, and sarcosinate , fatty acid amide ether sulfates, alkylamidobetaines, fatty alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, linolin derivatives, or ethoxylated glycerol fatty acid esters.
본 발명의 화장료 조성물은 살진균제, 굴수성 유발물질, 보습제, 방향제, 방향제 담체, 단백질, 용해화제, 당 유도체, 일광차단제, 비타민, 식물 추출물 등을 포함하는 부형제를 추가로 함유할 수 있다.The cosmetic composition of the present invention may further contain excipients including fungicides, hydrotropes, humectants, fragrances, fragrance carriers, proteins, solubilizers, sugar derivatives, sunscreens, vitamins, plant extracts, and the like.
본 발명은 또한, 매생이 추출물을 유효성분으로 포함하는 자외선(ultraviolet)에 의한 피부 손상의 예방 또는 치료용 피부 외용제를 제공한다.The present invention also provides an external skin preparation for preventing or treating skin damage caused by ultraviolet rays (ultraviolet) comprising an extract of Maesaengii as an active ingredient.
본 발명의 피부 외용제는 본 발명의 추출물을 다양한 방식 또는 형태로 인체에 적용될 수 있으나, 바람직하게는 피부에 국소적으로 도포되어 적용 가능한 피부 외용제의 제형으로 제조될 수 있다. 예를 들어, 파우더, 연고제, 겔제, 크림제, 리니멘트제, 로션제, 액제, 또는 에어로졸제 등을 들 수 있으나, 이에 한정되는 것은 아니다.The external skin preparation of the present invention may be applied to the human body with the extract of the present invention in various ways or forms, but preferably, it may be prepared as a formulation of an external skin preparation that can be applied topically to the skin. For example, powders, ointments, gels, creams, liniments, lotions, liquids, or aerosols may be mentioned, but are not limited thereto.
상기 피부 외용제로 제제화할 경우, 본 발명의 추출물 외에 첨가물 등을 적절하게 배합하여 제조할 수 있다. 상기 첨가물은 당 업계에서 통상적으로 이용되는 것으로, 본 발명의 목적 및 효과를 손상시키지 않는 범위 내에서 배합 가능하다.When formulated as the external skin preparation, it can be prepared by appropriately blending additives and the like in addition to the extract of the present invention. The above additives are commonly used in the art, and may be formulated within a range not impairing the objects and effects of the present invention.
본 발명은 또한, 매생이 추출물을 유효성분으로 포함하는 피부 보습용 건강기능식품 조성물을 제공한다.The present invention also provides a health functional food composition for moisturizing the skin containing the extract of Maesaengi as an active ingredient.
본 발명의 건강기능식품 조성물에 있어서, 상기 매생이 추출물은 전술한 바와 같다.In the health functional food composition of the present invention, the maesaengi extract is as described above.
본 발명의 상기 피부 보습용 건강기능성 식품은 다양한 형태의 식품 첨가제 또는 기능성 식품을 제공할 수 있다. 상기 피부 보습용 건강기능성 식품으로 예를 들면, 액상차, 음료, 발효유, 치즈, 젤리, 요구르트, 주스, 생균 제제 및 건강보조식품 등으로 가공될 수 있으며, 그 외 목적에 따라 다양한 식품 첨가제의 형태로 사용될 수 있다. 또한, 건강기능성 식품의 제형은 용액, 유화물, 점성형 혼합물, 타블렛, 분말, 환 등의 다양한 형태일 수 있다.The health functional food for moisturizing the skin of the present invention may provide various types of food additives or functional foods. The health functional food for moisturizing the skin may be processed into, for example, liquid tea, beverages, fermented milk, cheese, jelly, yogurt, juice, probiotic preparations and health supplements, and may be in the form of various food additives depending on other purposes. can be used as In addition, the dosage form of health functional food may be in various forms such as solutions, emulsions, viscous mixtures, tablets, powders, and pills.
바람직하게는, 상기 피부 보습용 건강기능성 식품은 이너뷰티 푸드(inner beauty food) 형태로 섭취함으로써 더욱 우수한 효과를 갖는 장점을 가진다. 상기 이너뷰티 푸드(inner beauty food)는 '먹는 화장품 또는 뷰티 푸드'로 일컬어지는 푸드로, 피부에 좋은 여러 가지 성분을 몸속으로 흡수시켜 피부 체질을 건강하게 바꾸는 식품을 지칭하며, 피부 타입에 맞는 화장품을 고르듯 피부 컨디션과 라이프스타일을 고려해 개개인에게 맞는 이너뷰티 푸드를 선택하여 섭취할 수 있다. 보다 바람직하게는 상기 매생이 추출물을 포함하는 화장품과 상기 추출물을 포함하는 이너뷰티 푸드를 혼용할 경우, 화장품만 사용하는 것에 비해 UV 조사에 의해 감소된 세포 생존율과 피부 보습 및 피부 장벽과 관련된 단백질(필라그린 및 인볼루크린)의 발현량 증진 효과가 월등히 높아져 더욱 효과적으로 피부 장벽이 강화된 효과를 볼 수 있는 장점을 가진다.Preferably, the health functional food for moisturizing the skin has the advantage of having a more excellent effect by ingesting it in the form of inner beauty food. The inner beauty food is a food referred to as 'eating cosmetics or beauty food', and refers to food that changes the skin constitution to be healthy by absorbing various ingredients good for the skin into the body, and cosmetics suitable for the skin type. You can select and consume inner beauty food that suits each individual by considering skin condition and lifestyle. More preferably, when the cosmetics containing the extract of Maesaengi and the inner beauty food containing the extract are mixed, the cell viability reduced by UV irradiation and proteins related to skin moisturizing and skin barrier (pillar) compared to using only cosmetics Green and involucrin) have the advantage of being able to see the effect of strengthening the skin barrier more effectively because the effect of increasing the expression level is significantly increased.
이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by examples. However, the following examples are only to illustrate the present invention, and the content of the present invention is not limited to the following examples.
재료 및 방법Materials and Methods
1. 매생이 에탄올 추출물의 제조1. Preparation of Maesaengi Ethanol Extract
생매생이(완도에서 구입)를 증류수로 2회 세척하고 물기를 제거한 후 상기 세척된 생매생이 150g에 50%(v/v) 에탄올 900㎖을 첨가하고 실온 또는 40℃에서 6, 12 또는 24시간 동안 추출한 다음 감압농축기로 농축하고 동결건조하였다. 다양한 추출 조건에 따른 수율을 비교한 결과, 매생이와 에탄올 혼합물을 40℃에서 6시간 동안 추출했을 때 수율이 가장 높음을 확인하였다(표 1).After washing and drying the fresh celery (purchased from Wando) twice with distilled water and removing the water, 900 ml of 50% (v/v) ethanol was added to 150 g of the washed celery, and incubated at room temperature or 40 ° C for 6, 12 or 24 hours. After extraction, it was concentrated in a vacuum concentrator and lyophilized. As a result of comparing the yield according to various extraction conditions, it was confirmed that the highest yield was obtained when the maesaengi and ethanol mixture was extracted at 40 ° C. for 6 hours (Table 1).
2. 세포 배양2. Cell culture
실험에 사용된 피부각질세포(HaCaT)는 10% FBS(fetal bovine serum)와 1%의 항생제(penicillin/streptomycin)가 함유된 DMEM 배지(Dulbecco's Modified Eagle Medium)를 사용하여 37℃, 5% CO2 조건에서 배양하였다. 배지는 2일 간격으로 교환하였고 트립신(trypsin-EDTA)을 처리하여 계대배양하였다.The keratinocytes (HaCaT) used in the experiment were prepared in DMEM medium (Dulbecco's Modified Eagle Medium) containing 10% fetal bovine serum (FBS) and 1% antibiotics (penicillin/streptomycin) at 37°C and 5% CO 2 cultured under the condition. The medium was exchanged every 2 days and subcultured by treatment with trypsin (trypsin-EDTA).
3. MTT 어세이3. MTT assay
HaCaT 세포를 96-웰 배양용기에 1×103 cells/well로 분주하고 24시간 동안 배양한 후 매생이 추출물을 농도별(25, 50 또는 100㎍/㎖)로 처리하여 24시간 동안 배양하였다. 배양된 세포에 MTT[3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tertrazolium bromide, 2mg/㎖)]용액을 처리하고 4시간 동안 반응시킨 후 MTT 용액을 제거하고 DMSO를 처리하여 암실에서 30분 동안 반응시킨 다음 흡광도 측정기로 540nm에서 흡광도를 측정하였다. 세포 생존율은 시료를 처리하지 않은 대조군의 값과 비교하여 퍼센트(%)로 산출하였다.HaCaT cells were dispensed at 1×10 3 cells/well in a 96-well culture vessel and cultured for 24 hours, and then treated with the extract of Maesaengi by concentration (25, 50 or 100 μg/ml) and cultured for 24 hours. The cultured cells were treated with MTT [3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tertrazolium bromide, 2mg/ml)] solution and allowed to react for 4 hours, then the MTT solution was removed and treated with DMSO. After reacting for 30 minutes in a dark room, absorbance was measured at 540 nm using an absorbance meter. Cell viability was calculated as a percentage (%) compared to the value of the control group in which the sample was not treated.
또한, 자외선(UVB) 처리에 따른 세포 생존율을 측정할 경우에는 HaCaT 세포가 배양된 96-웰 배양용기에 매생이 추출물을 농도별로 1시간 동안 전처리하고 PBS(phosphate buffered saline)를 넣은 상태에서 UVB(300mJ/cm2)를 조사한 후 무혈청(serum free) 배지를 넣고 24시간 동안 배양한 후 MTT 용액을 처리하고 4시간 동안 반응시켰다. 반응이 끝난 후 상기 전술한 것과 동일한 방법으로 흡광도를 측정하였다.In addition, when measuring the cell viability according to ultraviolet (UVB) treatment, the HaCaT cell cultured 96-well culture container was pretreated for 1 hour by concentration, and UVB (300mJ) was added in PBS (phosphate buffered saline). / cm 2 ) After irradiation, a serum-free medium was added and incubated for 24 hours, and then treated with MTT solution and reacted for 4 hours. After the reaction was completed, absorbance was measured in the same manner as described above.
4. 웨스턴 블롯(Western blot) 4. Western blot
자외선(UVB)이 처리된 HaCaT 세포를 대상으로 웨스턴 블롯을 수행하기 위해, HaCaT 세포를 6-웰 배양용기에 5×104 cells/well로 분주하고 24시간 동안 배양한 후 매생이 추출물을 농도별(25, 50 또는 100㎍/㎖)로 처리하여 1시간 동안 전처리하고, PBS를 넣은 상태에서 UVB(300mJ/cm2)를 조사한 후 무혈청(serum free) 배지를 넣고 24시간 동안 배양한 다음 PBS로 2회 세척하고 분해 버퍼(lysis buffer; RIPA buffer, 5% protease inhinitor cocktail)를 첨가하여 단백질을 추출하고 13,000rpm, 4℃에서 20분 동안 원심분리하여 층액을 회수하였다. 회수한 상층액은 브래드포드 용액(Breadford reagent)을 사용하여 단백질을 정량하였고, 정량된 단백질은 10% SDS-폴리아크릴아마이드 겔(polyacrylamide gel)에 로딩하여 전기영동을 실시한 후 니트로셀룰로스 멤브레인(nitrocellulose membrane)에 트랜스퍼하였다. 트랜스퍼가 끝난 후 5% 탈지유(skim milk)로 블로킹시키고, 필라그린(filament aggregating protein, filaggrin) 및 인볼루크린(involucrin)의 1차 항체(NovusBio, 미국) 및 2차 항체(Jackson ImmunoResearch, 미국)를 사용하여 반응시킨 다음 ECL 키트를 사용하여 단백질 발현량을 확인하였다.In order to perform Western blotting on HaCaT cells treated with ultraviolet (UVB), HaCaT cells were dispensed at 5×10 4 cells/well in a 6-well culture vessel and cultured for 24 hours, and then the extracts of Maesaengi were prepared by concentration ( 25, 50 or 100 μg/ml) and pre-treated for 1 hour, irradiated with UVB (300mJ/cm 2 ) in PBS, and then cultured for 24 hours in serum-free medium and then with PBS. After washing twice, protein was extracted by adding lysis buffer (RIPA buffer, 5% protease inhibitor cocktail), and centrifugation was performed at 13,000 rpm and 4° C. for 20 minutes to recover the layer solution. In the collected supernatant, proteins were quantified using Breadford reagent, and the quantified proteins were loaded on a 10% SDS-polyacrylamide gel, electrophoresed, and then nitrocellulose membrane ) was transferred to. After transfer, blocking with 5% skim milk, primary antibodies (NovusBio, USA) and secondary antibodies (Jackson ImmunoResearch, USA) of filaggrin and involucrin After reacting using the ECL kit, the protein expression level was confirmed.
실시예 1. HaCaT 세포에서 매생이 추출물의 세포 생존율 분석Example 1. Analysis of cell viability of the extract of Maesaengi in HaCaT cells
매생이 추출물의 세포 독성을 확인하기 위해 HaCaT 세포에 매생이 추출물을 농도별(25, 50 또는 100㎍/㎖)로 처리하고 MTT 어세이를 수행한 결과, 대조군(매생이 추출물 무처리)과 매생이 추출물 처리군의 세포 생존율이 유사한 수준인 것을 확인하였다(도 1A). 이를 통해 본 발명의 매생이 에탄올 추출물은 피부 세포에 독성이 없음을 알 수 있었다.To confirm the cytotoxicity of Maesaengi extract, HaCaT cells were treated with Maesaengi extract at different concentrations (25, 50, or 100 μg/ml) and MTT assay was performed. It was confirmed that the cell viability of was at a similar level (FIG. 1A). Through this, it was found that the ethanol extract of Maesaengi of the present invention was not toxic to skin cells.
또한, 매생이 추출물의 세포 보호 효과를 확인하기 위해 HaCaT 세포에 매생이 추출물을 농도별로 전처리하고 UVB를 조사한 후 MTT 어세이를 수행한 결과, UVB 조사에 의해 61.2%까지 감소된 세포 생존율이 매생이 추출물 전처리에서 회복되었고, 특히 매생이 추출물 100㎍/㎖ 처리군에서는 83.2%까지 세포 생존율이 증가된 것을 확인하였다(도 1B). 이를 통해, 본 발명의 매생이 에탄올 추출물은 자외선에 의해 발생되는 피부 손상에 대한 피부 세포 보호 효과가 우수함을 알 수 있었다. In addition, in order to confirm the cytoprotective effect of Maesaengi extract, HaCaT cells were pretreated with Maesaengi extract by concentration, irradiated with UVB, and then MTT assay was performed. It was recovered, and in particular, it was confirmed that the cell viability increased up to 83.2% in the group treated with 100 μg/ml of Maesaengii extract (FIG. 1B). Through this, it was found that the ethanol extract of Maesaengi of the present invention has an excellent skin cell protection effect against skin damage caused by ultraviolet rays.
실시예 2. HaCaT 세포에서 피부 보습 및 피부 장벽 관련 단백질의 발현량 분석Example 2. Analysis of the expression level of skin moisturizing and skin barrier related proteins in HaCaT cells
매생이 추출물이 피부 보습 및 피부 장벽 기능에 미치는 영향을 살펴보기 위해 웨스턴 블롯을 통해 필라그린 및 인볼루크린의 발현량을 분석한 결과, 대조군(UVB 및 매생이 추출물 무처리)에 비해 UVB 단독 처리군에서 필라그린 및 인볼루크린의 발현량이 약 60%까지 현저히 감소하였으나, 매생이 추출물을 전처리한 후 UVB를 조사한 군에서는 UVB 단독 처리군에 비해 필라그린 및 인볼루크린의 발현 수준이 높음을 확인할 수 있었고, 특히 매생이 추출물 100㎍/㎖ 처리군에서는 필라그린 및 인볼루크린의 발현 수준이 약 92~98%로 정상 수준(대조군)과 큰 차이가 없음을 알 수 있었다(도 2). As a result of analyzing the expression levels of filaggrin and involucrin through Western blot to examine the effect of Maesaengi extract on skin moisturizing and skin barrier function, the UVB alone treatment group compared to the control group (UVB and Maesaengi extract untreated) Although the expression levels of filaggrin and involucrin were significantly reduced by about 60%, it was confirmed that the expression level of filaggrin and involucrin was higher in the group irradiated with UVB after pretreatment with the extract of Maesaengi, compared to the group treated with UVB alone. In particular, in the group treated with 100 μg / ml of Maesaengi extract, it was found that the expression level of filaggrin and involucrin was about 92-98%, which was not significantly different from the normal level (control group) (FIG. 2).
필라그린은 표피 단백질의 일종으로, 각질층이 생성되는 과정에서 프로필라그린(profilaggrin), 필라그린(filaggrin), 천연보습인자(natural moisturizing factor; NMF) 등의 형태로 가공되며, 최종적으로 NMF를 이루게 되는데 이는 각질층의 20~30%(건조중량기준)를 이루고 수분을 흡수하는 성질이 뛰어나 각질층의 수분을 조절하는 습윤제(humectant)의 역할을 한다. 또한, 인볼루크린은 각질화 세포 표피의 주요한 구조 구성단백질로, 정상 표피에서는 상부 유극층과 과립층에서 나타나기 시작하고 합성된 후에는 세포막 가까이에 위치하여 트랜스글루타미다아제(transglutamidase)에 의해 막단백질에 결합되어 지지체 역할을 한다.Filaggrin is a type of epidermal protein, and is processed into forms such as profilaggrin, filaggrin, and natural moisturizing factor (NMF) in the process of generating the stratum corneum, and finally forms NMF. It constitutes 20 to 30% of the stratum corneum (based on dry weight) and has excellent water absorption properties, so it acts as a humectant to control the moisture in the stratum corneum. In addition, involucrin is a major structural component of the epidermis of keratinized cells. In normal epidermis, it begins to appear in the upper spinous layer and the granular layer, and after being synthesized, it is located close to the cell membrane and is converted to a membrane protein by transglutamidase. attached to serve as a support.
따라서, 본 발명의 매생이 에탄올 추출물은 자외선 조사에 의한 필라그린 및 인볼루크린의 손실을 억제하여 피부 보습 및 피부 장벽 기능을 강화시키는 효과가 우수하므로, 외부 자극에 의해 손상된 피부의 개선을 위한 화장료 및 건강기능성 식품의 소재로 사용될 수 있을 것으로 사료되었다.Therefore, the ethanol extract of Maesaengi of the present invention suppresses the loss of filaggrin and involucrin by ultraviolet irradiation and is excellent in moisturizing the skin and strengthening the skin barrier function, so cosmetics for improving skin damaged by external stimuli and It was thought that it could be used as a material for health functional food.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200021394A KR102573041B1 (en) | 2020-02-21 | 2020-02-21 | Composition for skin moisturizing comprising Capsosiphon fulvescens extract as effective component |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200021394A KR102573041B1 (en) | 2020-02-21 | 2020-02-21 | Composition for skin moisturizing comprising Capsosiphon fulvescens extract as effective component |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210106660A KR20210106660A (en) | 2021-08-31 |
KR102573041B1 true KR102573041B1 (en) | 2023-08-31 |
Family
ID=77489394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200021394A KR102573041B1 (en) | 2020-02-21 | 2020-02-21 | Composition for skin moisturizing comprising Capsosiphon fulvescens extract as effective component |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102573041B1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100542446B1 (en) * | 2003-07-25 | 2006-01-11 | 한불화장품주식회사 | A cosmetic composition containing an extract of capsosiphon fulvescens |
KR20110014820A (en) * | 2009-08-06 | 2011-02-14 | 가톨릭대학교 산학협력단 | Polysaccharide extracted from capsosiphon fulvescens having anti-coagulation and immunostimulating effect, composition containing polysaccharide and process thereof |
KR20120000251A (en) * | 2010-06-25 | 2012-01-02 | 신라대학교 산학협력단 | A cosmetic composition comprising laminaria japonica |
KR101873336B1 (en) * | 2016-10-14 | 2018-07-03 | (주)뷰티화장품 | Method for preparing hydrogel pack comprising bioactive components of seaweed and hydrogel pack prepared thereby |
-
2020
- 2020-02-21 KR KR1020200021394A patent/KR102573041B1/en active IP Right Grant
Non-Patent Citations (1)
Title |
---|
네이버 블로그, "알리제코리아 플란테마린 수분크림으로 꿀광피부 완성"(2016.01.18.) 1부.* |
Also Published As
Publication number | Publication date |
---|---|
KR20210106660A (en) | 2021-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101819727B1 (en) | Composition containing ginseng berry extract using processing of herbal medicine | |
KR20220091957A (en) | Composition for anti-aging, anti-inflammation or skin regeneration containing Cannabis sativa stem extract as effective component | |
JP2023171950A (en) | Anti-aging agent, antioxidant, anti-inflammatory agent, and whitening agent, as well as cosmetic | |
KR101860109B1 (en) | Skin external composition containing floral ginsenoside | |
KR20070019120A (en) | Anti-Wrinkle Cosmetic Composition Comprising the Extract of Paeonia lactiflora as Active Ingredient | |
CN110072516A (en) | Cosmetic combination comprising the Chinese medicinal material extract as effective component | |
KR102068736B1 (en) | A cosmetic composition for anti-aging comprising extract of coffee grounds | |
KR101758144B1 (en) | Composition for anti-aging containing youngia denticulata extract | |
JP4891274B2 (en) | Biaryl compounds and cosmetics | |
KR20170055172A (en) | Cosmetic Composition Comprising Extracts of Centipeda minima | |
KR101449282B1 (en) | Composition for improving skin wrinkle and skin moisturing comprising Barley fermented by Pichia jadinii and Aureobasidium pullulans bacteria | |
KR102344701B1 (en) | Cosmetic composition having high functional natural fermentation extracts | |
KR20210155987A (en) | Composition Comprising Complex Extract of seaweeds Fermented by Lactobacillus Brevis with Anti-Wrinkling and Elasticity, Antioxidant, and Skin Hydration Property as Active Ingredient | |
KR100955572B1 (en) | Cosmetic composition comprising a supercritical fluid extract of Morinda citrifolia | |
KR20140137540A (en) | Method for preparing mugwort extract and cosmetic composition comprising mugwort extract prepared therefrom | |
KR101578908B1 (en) | Extract of fermentative Zizyphus jujuba Fructus by Laetiporus sulphureus having lifespan extention of C. elegans via stress response and increasing collegen synthesis, and its cosmetic and therapeutic agent for wrinkle containing the same | |
TW202017560A (en) | Composition for improving skin transparency and dullness | |
KR102573041B1 (en) | Composition for skin moisturizing comprising Capsosiphon fulvescens extract as effective component | |
KR20190021114A (en) | Composition for anti-inflammation, inhibiting secretion of sebum, or treating acne on the skin comprising plant extract | |
KR20040087644A (en) | Cosmetic Composition Comprising Pyrus communis L. Extract for Skin Whitening | |
KR101924446B1 (en) | Composition containing ginseng berry extract using processing of herbal medicine | |
KR101971257B1 (en) | A cosmetic composition comprising tenebrio molitor extract | |
KR101926179B1 (en) | Cosmetic composition containing canavalia lineata extract for moisturizing and anti-wrinkle effects on the skin | |
KR20180099563A (en) | Cosmetic composition for improving skin wrinkle comprising Oxya chinensis sinuosa extract or compound isolated from the extract as effective component | |
EP3510991A1 (en) | Skin anti-aging composition containing dehydrogenated abietic acid and compound k |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant |